FDA limits use of J&J vaccine over rare blood clots
Authors: PETER SULLIVAN – 05/05/22 THE HILL The Food and Drug Administration (FDA) on Thursday announced that it is limiting the authorization for the Johnson & Johnson COVID-19 to people who cannot or will not get other versions of the vaccine, citing the risk of rare blood clots. The authorization for the J&J vaccine, also […]